Clinical Trials in San Antonio

Showing 2661-2680 of 7,028 trials

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

NCT03653091

The Revita™ System is being investigated to assess the ability to improve glycemic control in conjunction with diet and exercise in patients with Type 2 diabetes who are inadequately controlled with oral anti-diabetic medications. The purpose of this study is to demonstrate the safety and effectiveness of the Fractyl DMR Procedure using the Revita™ System compared to a sham procedure. At 24 weeks, subjects randomized to the DMR procedure be continued to be followed per protocol till 48 Weeks and the Sham treatment arm will be offered to cross over to receive the DMR treatment and will be followed per protocol for 24 weeks post treatment.

Type 2 Diabetes

Fractyl Health Inc.9 participantsStarted Sep 2018

Orlando, Florida, United States • Boston, Massachusetts, United States • Lebanon, New Hampshire, United States +3 more locations

UNKNOWN< 1 mile

Lung EpiCheck Biomarkers Development Study

NCT06245876

This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.

Lung Cancer

Nucleix Ltd.6,000 participantsStarted May 2022

Miami, Florida, United States • Panama City, Florida, United States • Shreveport, Louisiana, United States +7 more locations

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

Lung EpiCheck Biomarkers Development Study

Find Trials by Condition in San Antonio

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

Pleconaril Enteroviral Sepsis Syndrome

STAT: Standard Therapy Plus Active Therapy

A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis

Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure

ILLUMENATE Pivotal Post-Approval Study (PAS)

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer